GeneDx Holdings Corp. (WGS) is currently Overvalued by 33.43%

Instant valuation answer

GeneDx Holdings Corp. (WGS) appears overvalued by approximately 33.43% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.

  • Downside (live) 33.43% (from live valuation API)
  • Confidence (live) 8.5/10 (High conviction overvalued)

Confidence Score is based on the magnitude of upside or downside vs intrinsic value.

Fair value estimate

Unlock fair value

Current price

$65.42

Stock valuation checker

Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.

Explore Our Valuation Calculators

Why is GeneDx Holdings Corp. overvalued or undervalued?

Intrinsic value work anchors GeneDx Holdings Corp. on owner earnings and balance-sheet capacity; the current quote trades above that anchor, which frames the stock as relatively rich on a fundamentals-first view.

Versus historical valuation bands, WGS is closer to the upper end of where this business has traded when profitability and growth were comparable—useful context before reading any single headline multiple.

Forward market expectations are elevated: the price requires heroic assumptions to converge with our fair-value zone, but sector peers and macro rates still deserve a quick sanity check on the company page.

Key metrics

P/E ratio
21.4x
Revenue growth (TTM y/y)
20%
Profit margin
38.7%
Fair value (model)
Unlock

Frequently asked questions — WGS

Is WGS overvalued right now?

Based on our 2026 models, GeneDx Holdings Corp. (WGS) appears overvalued at $65.42 with roughly 33.4% downside versus fair value. Confirm with valuation ratios and financials before acting.

What is GeneDx Holdings Corp.'s intrinsic value?

Our DCF, P/E Multiple, and P/S Multiple models estimate whether WGS trades above or below fair value. At $65.42, GeneDx Holdings Corp. currently looks overvalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.

How is GeneDx Holdings Corp.'s intrinsic value calculated?

Tickerplace calculates WGS's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.

Is WGS undervalued right now?

A stock is undervalued when price sits below a supportable fair value range. Check whether WGS's gap aligns with fundamentals using the ratios and financial links on this page.

Peers for WGS: open their overvalued / undervalued view.